• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对人类血管活性肠肽(VIP)1受体胞外域内半胱氨酸残基的突变分析鉴定出七个在VIP结合方面存在缺陷的突变体。

Mutational analysis of cysteine residues within the extracellular domains of the human vasoactive intestinal peptide (VIP) 1 receptor identifies seven mutants that are defective in VIP binding.

作者信息

Gaudin P, Couvineau A, Maoret J J, Rouyer-Fessard C, Laburthe M

机构信息

Unité de Neuroendocrinologie et Biologie Cellulaire Digestives, INSERM U 410, Faculté de Médecine Xavier Bichat, Paris, France.

出版信息

Biochem Biophys Res Commun. 1995 Jun 26;211(3):901-8. doi: 10.1006/bbrc.1995.1897.

DOI:10.1006/bbrc.1995.1897
PMID:7598720
Abstract

We have used site-directed mutagenesis to investigate the requirement of cysteine residues in the extracellular domains of the human VIP 1 receptor for binding VIP. Cys37, Cys50, Cys63, Cys72, Cys86, Cys105 and Cys122 (N-terminal extracellular domain), Cys208 and Cys215 (second extracellular loop) and Cys288 (third extracellular loop) were mutated into glycine, and mutated cDNAs transfected into Cos-7 cells. It appeared that mutants C50G, C63G, C72G, C86G, C105G, C122G, and C288G did not bind VIP whereas mutants C37G, C208G and C215G bound VIP with the same dissociation constant (#0.5 nM) as the wild-type receptor. All mutated receptor proteins were synthesized by Cos-7 cells (Western blot) and delivered at the plasma membrane level (confocal microscopy). The fact that C208G and C215G mutants retained a complete binding activity while the C288G mutant was inactive does not suggest the presence of a functionally relevant disulfide bond between the second and third extracellular loop of the human VIP receptor contrary to what has been shown in several other heptahelical receptors. It is also concluded that the six crucial cysteine residues, e.g., Cys50, Cys63, Cys72, Cys86, Cys105 and Cys122 in the N-terminal extracellular domain, may be functionally important by forming intramolecular disulfide bonds which help to maintain the topology for ligand binding in human VIP 1 receptors.

摘要

我们利用定点诱变技术研究了人血管活性肠肽1型(VIP 1)受体胞外域中半胱氨酸残基对结合血管活性肠肽(VIP)的必要性。将第37、50、63、72、86、105和122位半胱氨酸(N端胞外域)、第208和215位半胱氨酸(第二个胞外环)以及第288位半胱氨酸(第三个胞外环)突变为甘氨酸,并将突变的cDNA转染到Cos-7细胞中。结果显示,突变体C50G、C63G、C72G、C86G、C105G、C122G和C288G不结合VIP,而突变体C37G、C208G和C215G以与野生型受体相同的解离常数(约0.5 nM)结合VIP。所有突变的受体蛋白均由Cos-7细胞合成(蛋白质免疫印迹法)并定位于质膜水平(共聚焦显微镜观察)。与其他几种七螺旋受体的情况相反,C208G和C215G突变体保留了完整的结合活性,而C288G突变体无活性,这一事实并不表明人VIP受体的第二个和第三个胞外环之间存在功能相关的二硫键。研究还得出结论,N端胞外域中的六个关键半胱氨酸残基,如Cys50、Cys63、Cys72、Cys86、Cys105和Cys122,可能通过形成分子内二硫键在功能上具有重要意义,这些二硫键有助于维持人VIP 1受体中配体结合的拓扑结构。

相似文献

1
Mutational analysis of cysteine residues within the extracellular domains of the human vasoactive intestinal peptide (VIP) 1 receptor identifies seven mutants that are defective in VIP binding.对人类血管活性肠肽(VIP)1受体胞外域内半胱氨酸残基的突变分析鉴定出七个在VIP结合方面存在缺陷的突变体。
Biochem Biophys Res Commun. 1995 Jun 26;211(3):901-8. doi: 10.1006/bbrc.1995.1897.
2
Highly conserved aspartate 68, tryptophane 73 and glycine 109 in the N-terminal extracellular domain of the human VIP receptor are essential for its ability to bind VIP.人血管活性肠肽(VIP)受体N端胞外域中高度保守的天冬氨酸68、色氨酸73和甘氨酸109对其结合VIP的能力至关重要。
Biochem Biophys Res Commun. 1995 Jan 5;206(1):246-52. doi: 10.1006/bbrc.1995.1034.
3
Mutagenesis of N-glycosylation sites in the human vasoactive intestinal peptide 1 receptor. Evidence that asparagine 58 or 69 is crucial for correct delivery of the receptor to plasma membrane.人血管活性肠肽1受体中N-糖基化位点的诱变。天冬酰胺58或69对受体正确转运至质膜至关重要的证据。
Biochemistry. 1996 Feb 13;35(6):1745-52. doi: 10.1021/bi952022h.
4
Aspartate 196 in the first extracellular loop of the human VIP1 receptor is essential for VIP binding and VIP-stimulated cAMP production.人VIP1受体第一个细胞外环中的天冬氨酸196对于VIP结合及VIP刺激的cAMP产生至关重要。
Biochem Biophys Res Commun. 1997 Jan 13;230(2):289-92. doi: 10.1006/bbrc.1996.5949.
5
Role of cysteine residues in the N-terminal extracellular domain of the human VIP 1 receptor for ligand binding. A site-directed mutagenesis study.半胱氨酸残基在人VIP 1受体N端胞外结构域中对配体结合的作用。一项定点诱变研究。
Ann N Y Acad Sci. 1996 Dec 26;805:585-9. doi: 10.1111/j.1749-6632.1996.tb17524.x.
6
Site-directed mutagenesis of human vasoactive intestinal peptide receptor subtypes VIP1 and VIP2: evidence for difference in the structure-function relationship.人血管活性肠肽受体亚型VIP1和VIP2的定点诱变:结构-功能关系差异的证据
J Pharmacol Exp Ther. 1998 Feb;284(2):744-50.
7
[Directed mutagenesis of human recombinant receptors of vasoactive intestinal peptide of VIP1 and VIP2 type. Difference in structure-activity relationship].[人重组VIP1型和VIP2型血管活性肠肽受体的定向诱变。构效关系的差异]
Gastroenterol Clin Biol. 1997;21(5):365-9.
8
A disulfide bond between conserved cysteines in the extracellular loops of the human VIP receptor is required for binding and activation.人血管活性肠肽(VIP)受体胞外环中保守半胱氨酸之间的二硫键对于结合和激活是必需的。
FEBS Lett. 1997 Jul 21;412(1):141-3. doi: 10.1016/s0014-5793(97)00714-x.
9
Identification of a VIP-specific receptor in guinea pig tenia coli.
Am J Physiol Gastrointest Liver Physiol. 2001 Sep;281(3):G718-25. doi: 10.1152/ajpgi.2001.281.3.G718.
10
Mutational analysis of the human vasoactive intestinal peptide receptor subtype VPAC(2): role of basic residues in the second transmembrane helix.人血管活性肠肽受体亚型VPAC(2)的突变分析:第二个跨膜螺旋中碱性残基的作用
Br J Pharmacol. 2001 Aug;133(8):1249-54. doi: 10.1038/sj.bjp.0704195.

引用本文的文献

1
A new neuropeptide insect parathyroid hormone iPTH in the red flour beetle Tribolium castaneum.在赤拟谷盗中发现一种新的神经肽昆虫甲状旁腺激素 iPTH。
PLoS Genet. 2020 May 4;16(5):e1008772. doi: 10.1371/journal.pgen.1008772. eCollection 2020 May.
2
Vasoactive intestinal peptide induces proliferation of human hepatocytes.血管活性肠肽可诱导人肝细胞增殖。
Cell Prolif. 2018 Oct;51(5):e12482. doi: 10.1111/cpr.12482. Epub 2018 Jul 20.
3
The palmitoylation of the N-terminal extracellular Cys37 mediates the nuclear translocation of VPAC1 contributing to its anti-apoptotic activity.
N 端胞外半胱氨酸 37 的棕榈酰化介导了 VPAC1 的核转位,这有助于其抗凋亡活性。
Oncotarget. 2017 Jun 27;8(26):42728-42741. doi: 10.18632/oncotarget.17449.
4
Structural and functional insights into the juxtamembranous amino-terminal tail and extracellular loop regions of class B GPCRs.对B类G蛋白偶联受体近膜氨基末端尾部和细胞外环区域的结构与功能的见解
Br J Pharmacol. 2014 Mar;171(5):1085-101. doi: 10.1111/bph.12293.
5
Pharmacological characterization of human incretin receptor missense variants.人肠促胰岛素受体错义变异体的药理学特征。
J Pharmacol Exp Ther. 2010 Jan;332(1):274-80. doi: 10.1124/jpet.109.160531. Epub 2009 Oct 19.
6
Solution structure and mutational analysis of pituitary adenylate cyclase-activating polypeptide binding to the extracellular domain of PAC1-RS.垂体腺苷酸环化酶激活多肽与PAC1-RS细胞外结构域结合的溶液结构及突变分析
Proc Natl Acad Sci U S A. 2007 May 8;104(19):7875-80. doi: 10.1073/pnas.0611397104. Epub 2007 Apr 30.
7
The human vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor 1 (VPAC1) promoter: characterization and role in receptor expression during enterocytic differentiation of the colon cancer cell line Caco-2Cl.20.人血管活性肠肽/垂体腺苷酸环化酶激活肽受体1(VPAC1)启动子:在结肠癌细胞系Caco-2Cl.20肠细胞分化过程中对受体表达的特征及作用
Biochem J. 2000 May 1;347 Pt 3(Pt 3):623-32.